Abstract
Repetitive transcranial magnetic stimulation (rTMS) is an evidence based neurostimulation modality used to treat patients with Major Depressive Disorder (MDD). In spite that the duration of current a depressive episode has been put forward as a negative predictor for clinical outcome, little is known about the underlying neurobiological mechanisms of this phenomenon. To address this important issue, in a sample of 43 melancholic stage III treatment resistant antidepressant-free refractory MDD patients, we reanalysed regional cerebral glucose metabolism (CMRglc) before high frequency (HF)-rTMS treatment, applied to the left dorsolateral prefrontal cortex (DLPFC). Besides that a lower baseline cerebellar metabolic activity indicated negative clinical response, a longer duration of the depressive episode was a negative indicator for recovery and negatively influenced cerebellar CMRglc. This exploratory 18FDG PET study is the first to demonstrate that the clinical response of HF-rTMS treatment in TRD patients may depend on the metabolic state of the cerebellum. Our observations could imply that for left DLPFC HF-rTMS non-responders other brain localisations for stimulation, more specifically the cerebellum, may be warranted.
Similar content being viewed by others
References
Baeken, C., De Raedt, R., Van Hove, C., Clerinx, P., De Mey, J., & Bossuyt, A. (2009). HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectrums, 14(8), 439–448.
Baeken, C., Vanderhasselt, M. A., Remue, J., Herremans, S., Vanderbruggen, N., Zeeuws, D., et al. (2013). Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. Journal of Affective Disorders, 151(2), 625–631.
Baeken, C., Desmyter, S., Duprat, R., De Raedt, R., Van Denabbeele, D., Tandt, H., et al. (2014). Self-directedness: an indicator for clinical response to the HF-rTMS treatment in refractory melancholic depression. Psychiatry Research, 220(1–2), 269–274.
Baeken, C., Marinazzo, D., Everaert, H., Wu, G. R., Van Hove, C., Audenaert, K., et al. (2015). The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression: insights from 18FDG PET brain imaging. Brain Stimulation, 8(4), 808–815.
Bell-McGinty, S., Butters, M. A., Meltzer, C. C., Greer, P. J., Reynolds 3rd, C. F., & Becker, J. T. (2002). Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. American Journal of Psychiatry, 159(8), 1424–1427.
Berman, R. M., Narasimhan, M., Sanacora, G., Miano, A. P., Hoffman, R. E., Hu, X. S., et al. (2000). A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biological Psychiatry, 47(4), 332–327.
Berti, V., Mosconi, L., & Pupi, A. (2014). Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. PET Clinics, 9(2), 129–140.
Brakemeier, E. L., Luborzewski, A., Danker-Hopfe, H., Kathmann, N., & Bajbouj, M. (2007). Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). Journal of Psychiatric Research, 41, 395–403.
Brakemeier, E. L., Wilbertz, G., Rodax, S., Danker-Hopfe, H., Zinka, B., Zwanzger, P., et al. (2008). Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. Journal of Affective Disorders, 108, 59–70.
Brambilla, P., Barale, F., Caverzasi, E., & Soares, J. C. (2002). Anatomical MRI findings in mood and anxiety disorders. Epidemiologia e Psichiatria Sociale, 11(2), 88–99.
Brett, M., Anton, J-L., Valabregue, R., Poline, J-B. (2002). Region of interest analysis using an SPM toolbox [abstract]. Presented at the Eighth international conference of functional mapping of the human brain, June 2–6, 2002, Sendai, Japan, 16(2). Available on CD-ROM in NeuroImage 2002
Buckner, R. L. (2013). The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron, 80, 807–815.
Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014). The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychotherapy and Psychosomatics, 83(2), 70–88.
Cohen, R. B., Boggio, P. S., & Fregni, F. (2009). Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depression and Anxiety, 26(7), 682–688.
de Diego-Adeliño, J., Pires, P., Gómez-Ansón, B., Serra-Blasco, M., Vives-Gilabert, Y., Puigdemont, D., et al. (2014). Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychological Medicine, 44(6), 1171–1182.
De Raedt, R., Vanderhasselt, M. A., & Baeken, C. (2015). Neurostimulation as an intervention for treatment resistant depression: from research on mechanisms towards targeted neurocognitive strategies. Clinical Psychology Review, 41, 61–69.
Ferrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., et al. (2013). Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471–481.
George, M. S., & Post, R. M. (2011). Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. American Journal of Psychiatry, 168, 356–364.
Guo, W. B., Sun, X. L., Liu, L., Xu, Q., Wu, R. R., Liu, Z. N., et al. (2011). Disrupted regional homogeneity in treatment-resistant depression: a resting-state fMRI study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(5), 1297–1302.
Guo, W. B., Liu, F., Chen, J. D., Gao, K., Xue, Z. M., Xu, X. J., et al. (2012). Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study. Journal of Psychiatric Research, 46(10), 1366–1373.
Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social & Clinical Psychology, 6, 278–296.
Kimbrell, T. A., Little, J. T., Dunn, R. T., Frye, M. A., Greenberg, B. D., Wassermann, E. M., et al. (1999). Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry, 46(12), 1603–1613.
Lefaucheur, J. P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., et al. (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 125(11), 2150–2206.
Liu, F., Guo, W., Yu, D., Gao, Q., Gao, K., Xue, Z., et al. (2012). Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PloS One, 7(7), e40968.
Machino, A., Kunisato, Y., Matsumoto, T., Yoshimura, S., Ueda, K., Yamawaki, Y., et al. (2014). Possible involvement of rumination in gray matter abnormalities in persistent symptoms of major depression: an exploratory magnetic resonance imaging voxel-based morphometry study. Journal of Affective Disorders, 168, 229–235.
Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin, 65, 193–207.
Mayberg, H. S. (2009). Targeted electrode-based modulation of neural circuits for depression. Journal of Clinical Investigation, 119, 717–725.
Paillère Martinot, M. L., Galinowski, A., Ringuenet, D., Gallarda, T., Lefaucheur, J. P., Bellivier, F., et al. (2010). Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. International Journal of Neuropsychopharmacology, 13, 45–590.
Palazidou, E. (2012). The neurobiology of depression. British Medical Bulletin, 101, 127–145.
Peleman, K., Van Schuerbeek, P., Luypaert, R., Stadnik, T., De Raedt, R., De Mey, J., et al. (2010). Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research. World Journal of Biological Psychiatry, 11(2 Pt 2), 425–430.
Peng, H. J., Zheng, H. R., Ning, Y. P., Zhang, Y., Shan, B. C., Zhang, L., et al. (2013). Abnormalities of cortical-limbic-cerebellar white matter networks may contribute to treatment-resistant depression: a diffusion tensor imaging study. BMC Psychiatry, 13, 72.
Perugi, G., Medda, P., Zanello, S., Toni, C., & Cassano, G. B. (2012). Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimulation, 5(1), 18–24.
Phillips, J. R., Hewedi, D. H., Eissa, A. M., & Moustafa, A. A. (2015). The cerebellum and psychiatric disorders. Frontiers in Public Health, 3, 66.
Richieri, R., Boyer, L., Farisse, J., Colavolpe, C., Mundler, O., Lancon, C., et al. (2011). Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. European Journal of Nuclear Medicine and Molecular Imaging, 38(9), 1715–1722.
Richieri, R., Boyer, L., Faget-Agius, C., Farisse, J., Mundler, O., Lançon, C., et al. (2015). Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression. Psychiatry Research, 231(2), 134–140.
Rush, A. J., Thase, M. E., & Dubé, S. (2003). Research issues in the study of difficult-to-treat depression. Biological Psychiatry, 53, 743–753.
Schmahmann, J. D., & Pandya, D. N. (2008). Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex, 44, 1037–1066.
Schutter, D. J. (2009). Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychological Medicine, 39(1), 65–75.
Serra-Blasco, M., Portella, M. J., Gómez-Ansón, B., de Diego-Adeliño, J., Vives-Gilabert, Y., Puigdemont, D., et al. (2013). Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. British Journal of Psychiatry, 202, 434–440.
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 20, 22–57.
Speer, A. M., Benson, B. E., Kimbrell, T. K., Wassermann, E. M., Willis, M. W., Herscovitch, P., et al. (2009). Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. Journal of Affective Disorders, 115(3), 386–394.
Stoodley, C. J., & Schmahmann, J. D. (2010). Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex, 46, 831–844.
Su, L., Cai, Y., Xu, Y., Dutt, A., Shi, S., & Bramon, E. (2014). Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry, 14, 321.
Trevino, K., McClintock, S. M., McDonald Fischer, N., Vora, A., & Husain, M. M. (2014). Defining treatment-resistant depression: a comprehensive review of the literature. Annals of Clinical Psychiatry, 26(3), 222–232.
Van Overwalle, F., D'aes, T., & Mariën, P. (2016). Social cognition and the cerebellum: a meta-analytic connectivity analysis. Human Brain Mapping. doi:10.1002/hbm.23002.
van Randenborgh, A., Hüffmeier, J., Victor, D., Klocke, K., Borlinghaus, J., & Pawelzik, M. (2012). Contrasting chronic with episodic depression: an analysis of distorted socio-emotional information processing in chronic depression. Journal of Affective Disorders, 141(2–3), 177–184.
Van Strien, J. W. (2001). Handvoorkeur en taaldominantie. Neuropraxis, 2, 10–15.
Videbech, P., Ravnkilde, B., Pedersen, T. H., Hartvig, H., Egander, A., Clemmensen, K., et al. (2002). The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatrica Scandinavica, 106(1), 35–44.
Vieta, E., & Colom, F. (2011). Therapeutic options in treatment-resistant depression. Annals of Medicine, 43(7), 512–530.
Yoshizawa, H., Gazes, Y., Stern, Y., Miyata, Y., & Uchiyama, S. (2014). Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Psychiatry Research, 221(1), 78–85.
Acknowledgments
This research was supported by a grant from the Scientific Fund W. Gepts and by the Ghent University Multidisciplinary Research Partnership “The integrative neuroscience of behavioural control”. G.R.W. was supported by the Natural Science Foundation of China (Grant No. 61403312), and the Fundamental Research Funds for the Central Universities (Grant No. 2362014xk04).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Author Guo-Rong Wu and Author Chris Baeken declare that they have no conflict of interest.
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (http://www.wma.net/en/30publications/10policies/b3/), and the applicable revisions at the time of the investigation. Informed consent was obtained from all patients for being included in the study.
Rights and permissions
About this article
Cite this article
Wu, GR., Baeken, C. Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency?. Brain Imaging and Behavior 11, 8–16 (2017). https://doi.org/10.1007/s11682-016-9510-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-016-9510-0